AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistance
Type 2 diabetes is characterized by triglyceride accumulation and reduced lipid oxidation capacity in skeletal muscle. SIRT1 is a key protein in the regulation of lipid oxidation and its expression is reduced in the skeletal muscle of insulin resistant mice. In this tissue, Sirt1 up-regulates the ex...
Main Authors: | Laia Vil, Carles Roca, Ivet Elias, Alba Casellas, Ricardo Lage, Sylvie Franckhauser, Fatima Bosch |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-01-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Online Access: | http://www.sciencedirect.com/science/article/pii/S232905011630198X |
Similar Items
-
AAV8-mediated Sirt1 gene transfer to the liver prevents high carbohydrate diet-induced nonalcoholic fatty liver disease
by: Laia Vilà, et al.
Published: (2014-01-01) -
AAV-mediated BMP7 gene therapy counteracts insulin resistance and obesity
by: Estefania Casana, et al.
Published: (2022-06-01) -
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice
by: Cristina Mallol, et al.
Published: (2017-07-01) -
Overexpression of SIRT1 in rat skeletal muscle does not alter glucose induced insulin resistance.
by: Amanda E Brandon, et al.
Published: (2015-01-01) -
Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy
by: Joan Bertolin, et al.
Published: (2021-09-01)